financetom
Personal Finance
financetom
/
Personal Finance
/
TATA AIG launches 'Health Supercharge' with sum insured ranging from ₹5 lakh to ₹20 lakh
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TATA AIG launches 'Health Supercharge' with sum insured ranging from ₹5 lakh to ₹20 lakh
Nov 29, 2023 9:31 AM

TATA AIG General Insurance Company has launched “Health Supercharge” with a sum insured ranging from ₹5 lakh to ₹20 lakh. Customers can choose from options of two plan variants (Value Plan and Geo Plan), basis their geographical location, and other optional benefits offered under the product as per one’s requirement.

Live TV

Loading...

Speaking about the new health insurance policy – TATA AIG Health Supercharge, Santosh Puri, Senior Vice President – Health Product & Process, TATA AIG General Insurance said, “With the launch of Health Supercharge, we will be able to provide policyholders with 5X more coverage for their well-being."

Key highlights of Tata AIG Health Supercharge include:

The product introduces an enhanced level of coverage through a 5X supercharge bonus. This policy offers on each renewal a bonus of 50% of base sum insured of the expiring policy and accumulating maximum bonus up to 500% of the base sum insured in any policy year irrespective of claims.

Families below the age of 40 years or below at the time of first policy inception can benefit from an extra 5% discount which is also applicable upon policy renewals, irrespective of claims, the insurance company said.

The policy offers tailored flexibility with two plan variants (Value Plan & Geo Plan), and optional benefits such as unlimited restore, reduction of Pre-Existing Disease (PED) waiting period for named ailments.

Preventive annual health check-up can be availed by the insured persons once in a policy year, irrespective of claims, by paying an additional premium.

(Edited by : Anshul)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Hewlett Packard Enterprise Company
Research Alert: CFRA Keeps Buy Opinion On Shares Of Hewlett Packard Enterprise Company
Jun 4, 2025
10:55 AM EDT, 06/04/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our Buy rating and lift our 12-month target to $21 from $18, 9.5x our FY 26 EPS view, reflecting HPE's strong AI positioning despite execution challenges. We cut...
Research Alert: CFRA Lifts Opinion On Shares Of Dollar General Corporation To Hold From Sell
Research Alert: CFRA Lifts Opinion On Shares Of Dollar General Corporation To Hold From Sell
Jun 3, 2025
12:35 PM EDT, 06/03/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $118 from $75, 18x our FY 27 (Jan.) EPS of $6.55 (up from $5.99; FY 26 up to $5.82 from $5.34). This valuation places...
7 key quotes from investor Bill Ackman that could make you wealthier
7 key quotes from investor Bill Ackman that could make you wealthier
Jun 3, 2025
Bill Ackman is the billionaire investor behind the hedge fund Pershing Square Capital, and he's one of the most notable investors of the last two decades. Ackman typically bets big, with huge positions in stocks that are often momentarily out of favor or at least those where value has yet to be realized. Ackman often goes to the media to...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Jun 3, 2025
01:15 PM EDT, 06/03/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $343 from $321 based on our net present value analysis. We lift our 2025 EPS estimate to $0.69 from -$0.02, as we forecast improved...
Copyright 2023-2025 - www.financetom.com All Rights Reserved